6th International Conference

Clinical Cancer Prevention (SG-CAP 2010)

18-20 March 2010

With special reference to prevention of breast and prostate cancer and 1st international consensus on "chemoprevention of breast cancer"

 

 

program

 

Thursday, 18 March 2010

08.30-14.00

Registration

 

10.30-12.00

 

 

ISCaP Board Meeting

 

12.00-12.30

 

 ISCaP General Assembly 

12.30-13.30

 Lunch Break

 

13.30-14.00

Welcome Addresses

 

  • Welcome from the part of St.Gallen Oncology Conferences (SONK)

Hans-Jörg Senn, St.Gallen/Switzerland

 

  • Welcome from the part of the International Society of Cancer Prevention (ISCaP)

Jack Cuzick, London/UK

 

  • Welcome from the part of the European School of Oncology (ESO) 

 Alberto Costa, Milano/Italy

 

14.00-15.30

Session 1 Cancer Prevention and Health Politics: Economical and other Controversies

 

Chairs: Barbara K. Dunn, Bethesda MD/USA and Hans-Jörg Senn, St.Gallen/Switzerland

 

  • Modern cancer drugs - will they be affordable in the future?

Thomas Szucs, Zurich/Switzerland

 

  • The difficult direction of financial ressources in cancer: Tensions between primary prevention, early detection and treatment

Bruce Hillner, Richmond VA/USA 


  • Lessons learned from prevention programs: expectations, observations and possible considerations

Franz Porzsolt, Ulm/Germany

 

15.30-16.00

 

Coffee break 

16.00-17.30

Session 2 Cancer Prevention: The Scientific Base

 

Chairs: Eugene Gerner, Tucson AZ/USA and Adriana Albini, Milano/Italy

 

  • Genetics in cancer prevention

Judy Garber, Boston MA/USA

 

  • Biomarkers as surrogate end points in cancer prevention trials: Issues and opportunities

Barbara K. Dunn, Bethesda MD/USA

 

  • Targeting polyamines and inflammation for cancer prevention

Eugene Gerner, Tucson AZ/USA

 

  • Thinking about the role (largely ignored) of heavy metals in cancer prevention: chromium and melanoma as a case in point

Frank Meyskens, Orange CA/USA 

 

 Friday, 19 March 2010

 

08.30-10.00

 Session 3 Infection and Cancer Prevention: Hepatitis and H. pylori

 

Chairs: Frank Meyskens, Orange CA/USA and Hoyoku Nishino, Kyoto/Japan

 


  • Hepatitis B virus and cancer prevention

Mei-Hwei Chang, Taipei/Taiwan


  • Preventing hepatoma in chronic hepatitis C infection

Timothy R. Morgan, Long Beach CA/USA


  • H. pylori and gastric cancer in Latin American countries

Javier Torres, Ciudad de México FD/Mexico


 

10.00-10.30

Coffee Break, Posters

 

10.30-12.00

Session 4 Prevention of Prostate Cancer: PSA-Screening and beyond

 

Chairs: Fritz H. Schröder, Rotterdam/The Netherlands and Hans-Peter Schmid, St.Gallen/Switzerland

 


  • Nutritional aspects of primary prostate cancer prevention

Hans-Peter Schmid, St.Gallen/Switzerland


  • Prostate cancer prevention with 5 alpha reductase inhibitors

Dipen J Parekh, San Antonio TX/USA


  • PSA screening in early detection of prostate cancer

Fritz H. Schröder, Rotterdam/The Netherlands


 

12.00-12.30

Keynote Lecture: WHO’s Cancer Prevention Policies, Partnerships and Actions

Andreas Ullrich

 

 

12.30-14.00

Lunch Break , Posters

 

 

14.00-15.30

Session 5 HRT, Lifestyle and Breast Cancer Prevention

 

Chairs: Christine Friedenreich, Calgary Alberta/Canada and Gad Rennert, Haifa/Israel


  • Hormone replacement therapy and breast cancer risk

Anthony Howell, Manchester/UK


  • Commonly used medications associated with reduced risk of cancer – evidence and pitfalls

Gad Rennert, Haifa/Israel 

 

  • Physical activity and breast cancer risk: Epidemiologic evidence and biologic mechanisms

Christine Friedenreich, Calgary Alberta/Canada

 

 

15.30-16.00

Coffee break, Posters

 

16.00-17.30

Session 6 Chemoprevention of Breast Cancer: The Trial Facts 

 

Chairs: Trevor Powles, London/UK and Hans-Jörg Senn, St.Gallen/Switzerland

 

  • Chemoprevention of breast cancer by tamoxifen and raloxifene: The US-experience in NSABP-prevention trials

Victor Vogel, Pittsburgh PA/USA

 

  • Chemoprevention of breast cancer by newer SERMs and the future

Trevor Powles, London/UK

 

  • Chemoprevention of breast cancer: The European and Australian IBIS and other trial experience with Aromatase Inhibitors

John Forbes, Newcastle/Australia

 

  • Chemoprevention of breast cancer: The Italian experience with retinoids and low-dose Tamoxifen

Andrea Decensi, Genova/Italy

 

  • Chemoprevention of hormone-receptor-negative breast cancer: New approaches needed

Powel Brown, Houston TX/USA

 

 

 

 Saturday, 20 March 2010

 

08.30-10.00

 Session 7 International Expert Consensus on Breast Cancer Chemoprevention

 

Chairs: Jack Cuzick, London/UK and Florian Otto, St.Gallen/Switzerland

 

Panelists:

 

Banu Arun, Houston TX/USA

Powel Brown, Houston TX/USA

Monica Castiglione, Ittigen/Switzerland

Andrea Decensi, Genova/Italy

John Forbes, Newcastle/Australia

Judy Garber, Boston MA/USA

Agnes Glaus, St.Gallen/Switzerland

Anthony Howell, Manchester/UK

Barbara K. Dunn, Bethesda MD/USA

Gunther von Minckwitz, Neu-Isenburg/Germany

Trevor Powles, London/UK

Hans-Jörg Senn, St.Gallen/Switzerland

Victor Vogel, Pittsburgh PA/USA

Heinz Zwierzina, Innsbruck/Austria

 

10.00-10.30

Coffee Break

 

10.30-12.00

Session 8 (Continuation of sess. 7)

 

12.00-12.30

Farewell Adjourn

 

 

12.45

Guided Tours

 

 

St.Gallen Oncology Conferences, Rorschacherstr. 150, CH-9006 St.Gallen
info@oncoconferences.ch +41 (0) 71 243 00 32